نتائج البحث

...se T | title = Vasodilator mechanism of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1043–6 | yea ...944, a new calcium antagonist. A comparison with verapamil and diltiazem | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1056–9 | yea

...=Mónica L. |last6=Enriz |first6=Ricardo D. |journal=Bioorganic & Medicinal Chemistry |volume=16 |issue=7 |pages=3641–51 |pmid=18295494}}</ref>، يمكن أن

...4=Lennox B.|last5=Sancilio|first5=Lawrence F.|journal=Journal of Medicinal Chemistry|volume=22|issue=9|pages=1074–9}}

...or activity regulates serotonin release in the substantia nigra. ''Journal of Neurochemistry''. 2008 Nov;107(3):745-55. PMID 18761715</ref>

...f Monoamine Transporter Substrates | journal = Current Topics in Medicinal Chemistry | volume = 6 | issue = 17 | pages = 1845–1859 | year = 2006 | pmid = 1701 ...ation to Diethylpropion (Tenuate) | journal = Canadian Medical Association Journal | volume = 88 | issue= | pages = 943–944 | year = 1963 | month = May | pm

...r therapeutic interventions for herpes simplex virus epithelial keratitis |journal=Cochrane Database Syst Rev|volume=12 |pages= CD002898 |date=2010 |pmid= 211 ...f herpes keratitis with 5-iodo-2-deoxyuridine (IDU): a clinical evaluation of 1500 cases. ''Am. J. Ophthalmol''., 1963, 56, 571-573.</ref> إيدوكسو

* African Journal of Biotechnology

...ucture, Function, and Therapeutics | journal = Current Topics in Medicinal Chemistry | volume = 4 | issue = 1 | pages = 75–103 | year = 2004 | url = http://w ...eptors: Structure and Activity Relationships | journal = Current Medicinal Chemistry | volume = 11 | issue = 15 | pages = 2045–81 | date = August 2004 | url =

[[Image:Pharmacologyprism.jpg|thumb|right|300px|A variety of topics involved with pharmacology, including [[neuropharmacology]], renal p ...[[pharmacy]], a health services profession, is concerned with application of the principles learned from pharmacology in its clinical settings; whether

...as L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA562|date=24 January ...rnal|last1=Brodie|first1=Martin J.|title=Tiagabine Pharmacology in Profile|journal=Epilepsia|volume=36|issue=s6|year=1995|pages=S7–S9|issn=0013-9580|doi=10.

<ref name="ahren">{{cite journal | author = Augeri D ''et al.'' ...-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

| alt = Skeletal formula of desipramine | alt2 = Ball-and-stick model of the desipramine molecule

...ts: current understanding of mechanism of action and unanswered questions |journal= Int J Obes (Lond) |volume= 33 |issue= 9 |pages= 947–55 |date=September 2 ...00012189.pdf |العنوان=PUBLIC STATEMENT ON Acomplia (rimonabant) WITHDRAWAL OF THE MARKETING AUTHORISATION IN THE EUROPEAN UNION |الناشر=European Me

...ان=Marketing application for lacosamide (Vimpat) filed in EU for treatment of diabetic neuropathic pain|الأخير=Wan|الأول=Yuet|التاريخ=1 ...erstanding of the mechanism of action of the antiepileptic drug lacosamide|journal=Epilepsy Research|volume=110|الصفحات=189–205|التاريخ=2015|d

...s: structure/function, genetic polymorphisms and role in drug metabolism | journal = Pharmacol. Ther. | volume = 106 | issue = 3 | pages = 357&ndash;387 |date ...}} at approximately 2 hours.&nbsp;... MAS-XR, and LDX have a long duration of action at 12 hours postdose}}</ref>

...pabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17 | journal = Drug Metab. Dispos. | volume = 35 | issue = 8 | pages = 1292–300 | year ...y source of codeine for pharmaceutical use. It is considered the prototype of the weak to midrange [[opioids]] ([[tramadol]], [[dextropropoxyphene]], [[d